Family Medicine · Muskegon, MI
NPI
1154316222
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5933 Grand Haven Rd
Muskegon, MI, 49441
Phone (231) 799-3300
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
1,965 services
Medicare patients, 2024
106
Average age 72
Drug cost, 2024
$1.3M
12,548 prescriptions
Company payments, 2025
$1,982
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew N Powell was code 99457 (e&m - miscellaneous), 236 times for 32 patients. In total Matthew N Powell billed 1,965 services in 38 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99457 E&M - Miscellaneous | Office | 236 | 32 | $34.27 | $8,089 |
| 99214 Office E&M - Established | Office | 202 | 87 | $71.76 | $14K |
| 99454 E&M - Miscellaneous | Office | 166 | 30 | $32.69 | $5,426 |
| 99458 E&M - Miscellaneous | Office | 119 | 31 | $28.37 | $3,375 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 74 | 74 | $122.58 | $9,071 |
| 99213 Office E&M - Established | Office | 67 | 46 | $51.78 | $3,469 |
| 99453 E&M - Miscellaneous | Office | 29 | 29 | $9.85 | $286 |
| 81002 Clinical Chemistry | Office | 17 | 11 | $3.41 | $57.97 |
| 99212 Office E&M - Established | Office | 16 | 13 | $38.19 | $611 |
| G0008 Administration of influenza virus vaccine | Office | 14 | 14 | $29.40 | $412 |
| 90661 Vaccine Product | Office | 14 | 14 | $34.30 | $480 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 13 | 11 | $10.62 | $138 |
By year: 2022 $45K for 1,162 services; 2023 $44K for 880 services; 2024 $52K for 1,965 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 17 | 11 | $3.41 | $57.97 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew N Powell prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 986 prescriptions and refills. In total Matthew N Powell wrote 12,548 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 986 | 986 | 118 | $20K |
| Omeprazole Generic | 286 | 665 | 68 | $4,413 |
| Rosuvastatin Calcium Generic | 285 | 727 | 74 | $3,829 |
| Metoprolol Succinate Generic | 281 | 698 | 72 | $5,271 |
| Amlodipine Besylate Generic | 266 | 570 | 66 | $1,813 |
| Atorvastatin Calcium Generic | 238 | 634 | 67 | $3,291 |
| Gabapentin Generic | 238 | 380 | 52 | $3,254 |
| Alprazolam Generic | 233 | 265 | 38 | $1,064 |
| Levothyroxine Sodium Generic | 229 | 564 | 51 | $3,483 |
| Pantoprazole Sodium Generic | 222 | 545 | 58 | $3,026 |
| Morphine Sulfate Er Morphine Sulfate | 201 | 202 | 26 | $6,454 |
| Losartan Potassium Generic | 181 | 520 | 53 | $2,831 |
| Lorazepam Generic | 171 | 202 | 26 | $963 |
| Lisinopril Generic | 164 | 394 | 44 | $1,550 |
| Fluoxetine Hcl Generic | 158 | 335 | 36 | $1,970 |
Brand drugs: 1,321 claims; generic drugs: 11,130 claims; opioid claims: 1,794.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew N Powell $1,982 ($1,982 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $346.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $346 |
| Abbvie Inc. ABBV | 30 | $322 |
| Novo Nordisk Inc NVO | 15 | $274 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $199 |
| Stryker Corporation SYK | 1 | $175 |
| GlaxoSmithKline, LLC. GSK | 16 | $169 |
| Pfizer Inc. PFE | 11 | $165 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $39.28 |
| Lilly USA, LLC LLY | 2 | $35.85 |
| Amgen Inc. AMGN | 2 | $33.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.